Deals Summary, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 86
Table 61: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q1 2012 - Q4 2012 87
Table 62: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q1 2012 - Q4 2012 88
Table 63: Pharmaceuticals & Healthcare, Deals' Key Financials, Global Acquisition Deals, Q4 2011-Q4 2012 89
List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$m), Q4 2011 - Q4 2012 8
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), Q4 2012 10
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), Q4 2012 11
Figure 4: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$m), Q4 2011 - Q4 2012 14
Figure 5: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$m), by Therapy Area, Q4 2011 – Q4 2012 16
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 17
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$m), , Q4 2011 – Q4 2012 20
Figure 8: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 21
Figure 9: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), Q4 2012 23
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), Q4 2012 24
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q4 2011 - Q4 2012 25
Figure 1
'/>"/>
SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine technology :1.
Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends2.
Physicians Capital Investments Receives "Outstanding Development Award" for Sandy, Oregon Project3.
Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan4.
Kerry R. Hicks Joins Physicians Capital Investments as Vice-Chairman of Board5.
Frost & Sullivan: Investments in Healthcare Improvements to Bolster the Integration of Picture Archiving and Communications Systems in Latin America6.
Government Investments in Upgrades Sustain Laboratory Analytical Instrumentation Market in China, Finds Frost & Sullivan7.
Beyond Lucid Technologies Receives Funding From Dalmore Investments8.
Silicon Photonics: Big Investments, Small Business9.
Physicians Capital Investments, Physicians Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative10.
Berkery Noyes Releases First Half 2012 M&A Report For the Healthcare/Pharma Information and Technology Industry11.
Biopharma M&A Trends Hold Steady, But Deals Declined in 2011